Research and Development

Diater is working on different lines of R&D in the field of diagnosis, both in vivo and in vitro, and in the treatment of allergic diseases. Notable among them are the following:

Diagnosis of allergies to beta-lactams (DAP^®)

DAP^® is the first means of diagnosing hypersensitivity to beta-lactam antibiotics worldwide. This line of research is steadily adding more products to the pipeline to diagnose drug allergies.

VHC-Core

High-sensitivity serological diagnosis of antibodies against hepatitis C virus (HCV). This provides greater sensitivity than other serological diagnosis tests available at present and will allow a higher percentage of patients infected with HCV to be diagnosed.

Purified allergens for diagnosis and treatment.

Alt a 1 is the first purified major allergen from the fungus Alternaria alternata. It recognises more than 90% of the specific immunoglobulins E from the fungus. This technique for purifying major allergens is being developed for other allergens. Using purified major allergens in their native form increases the sensitivity and specificity of diagnosis, as well as the efficacy and safety of specific immunotherapy, compared to the complete allergen extract from the fungus.

New treatments for respiratory allergic diseases.

To make more convenient and effective treatments available to physicians and patients, at present, Diater is working on a line of research to study new forms of administration and new, safer and more effective types of extract that could reduce the current number of doses and duration of treatment for greater patient convenience.

The Diater applications laboratory provides the most advanced technologies to perform immunology and allergy studies, such as clinical reports, reports characterising new sources of allergens, purification of allergens, follow-up of immunological changes during immunotherapy and aid in diagnosis.

A whole range of services allow us, in collaboration with research centres and leading hospitals in different countries, to continue advancing each day towards more precise diagnosis and treatment.

Diater’s Research and Development department (R&D) has advanced techniques and the best equipment in the areas of chemical synthesis, proteomics and molecular biology.

To genuinely enhance the quality of life of patients with allergic diseases and improve diagnosis in areas that are not well covered, our programmes are conducted with support from international academic institutions as well as foundations and public organisations.